16 related articles for article (PubMed ID: 9509969)
1. Hematologic aspects of myeloablative therapy and bone marrow transplantation.
Riley RS; Idowu M; Chesney A; Zhao S; McCarty J; Lamb LS; Ben-Ezra JM
J Clin Lab Anal; 2005; 19(2):47-79. PubMed ID: 15756708
[TBL] [Abstract][Full Text] [Related]
2. Reticulocytes and reticulocyte enumeration.
Riley RS; Ben-Ezra JM; Goel R; Tidwell A
J Clin Lab Anal; 2001; 15(5):267-94. PubMed ID: 11574956
[No Abstract] [Full Text] [Related]
3. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.
Torres A; Sánchez J; Lakomsky D; Serrano J; Alvarez MA; Martín C; Valls C; Nevado L; Rodriguez A; Casaño J; Martínez F; Gómez P
Haematologica; 2001 Jan; 86(1):24-9. PubMed ID: 11146566
[TBL] [Abstract][Full Text] [Related]
4. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
7. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
8. Highly fluorescent reticulocytes after CD34+ peripheral blood progenitor cell transplantation.
Sica S; Salutari P; Laurenti L; Ortu La Barbera E; Zini G; d'Onofrio G; Serafini R; Leone G
Bone Marrow Transplant; 1998 Feb; 21(4):361-4. PubMed ID: 9509969
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
